Smoking cessation counselling and pharmacotherapy
Why it is asked so often
Smoking cessation is the one lifestyle step that appears again and again in the management of different diseases, so it is asked for when management is asked for. Where the advice is given in full rather than only named, it reads that smoking cessation programs and adjuncts are recommended.
The places it appears are worth holding together, because the exam asks for the management list and cessation is usually first on it:
- Hypertension: smoking cessation is one of the recommended lifestyle modifications, with alcohol moderation, diet, healthy drinks, physical activity, salt reduction, stress reduction and weight loss
- SLE: treatment opens with smoking cessation and avoidance of UV light, with NSAIDs for symptomatic relief, before pharmacotherapy
- COPD: management is smoking cessation, exercise as pulmonary rehabilitation, vaccination against influenza, pneumococcal and COVID, and then inhalers
- IPF: management is smoking cessation, exercise as pulmonary rehabilitation, the same vaccination, antifibrotic with pirfenidone or nintedanib, and LTOT
- Bronchiectasis: the long-term non-pharmacological plan is smoking cessation, chest physiotherapy and postural drainage exercises, and vaccinations
- Asthma: smoking cessation belongs with elimination of triggers, next to treat symptoms of GERD, domestic irritants and occupation exposures
What the tobacco does
Smoking and smokeless tobacco, for example chewing tobacco, increase the risk for all-cause mortality and are causal for ASCVD. Second-hand smoke is a cause of ASCVD and stroke. And even low levels of smoking increase the risk of acute myocardial infarction, so reducing the number of cigarettes per day does not totally eliminate risk. That last line is the answer to the patient who wants to cut down instead of stopping.
Electronic nicotine delivery systems (ENDS), known as e-cigarettes and vaping, are a new class of tobacco products that emit aerosol containing fine and ultrafine particulates, nicotine and toxic gases, which may increase the risk for CV and pulmonary diseases. Arrhythmias and hypertension with e-cigarette use have been reported, and chronic use is associated with persistent increases in oxidative stress and sympathetic stimulation in the healthy young. So an electronic nicotine delivery system is not offered here as the adjunct of choice.